222 related articles for article (PubMed ID: 32919424)
1. Autoimmune Hepatitis: a Review of Established and Evolving Treatments.
Bischoff S; Yesmembetov K; Antoni C; Sollors J; Evert M; Ebert M; Teufel A
J Gastrointestin Liver Dis; 2020 Sep; 29(3):429-443. PubMed ID: 32919424
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autoimmune hepatitis: a review of current and evolving therapies.
Jothimani D; Cramp ME; Mitchell JD; Cross TJ
J Gastroenterol Hepatol; 2011 Apr; 26(4):619-27. PubMed ID: 21073674
[TBL] [Abstract][Full Text] [Related]
3. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM; Stoelinga AEC; Gevers TJG; Pape S; Biewenga M; Tushuizen ME; Verdonk RC; de Jonge HJM; Vrolijk JM; Bakker SF; Vanwolleghem T; de Boer YS; Baven Pronk MAMC; Beuers U; van der Meer AJ; Gerven NMFV; Sijtsma MGM; van Eijck BC; van IJzendoorn MC; van Herwaarden M; van den Brand FF; Korkmaz KS; van den Berg AP; Guichelaar MMJ; Levens AD; van Hoek B; Drenth JPH;
J Hepatol; 2024 Apr; 80(4):576-585. PubMed ID: 38101756
[TBL] [Abstract][Full Text] [Related]
4. Update on autoimmune hepatitis.
Teufel A; Galle PR; Kanzler S
World J Gastroenterol; 2009 Mar; 15(9):1035-41. PubMed ID: 19266594
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis treatment in the elderly: A systematic review.
Durazzo M; Lupi G; Scandella M; Ferro A; Gruden G
World J Gastroenterol; 2019 Jun; 25(22):2809-2818. PubMed ID: 31236003
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
[TBL] [Abstract][Full Text] [Related]
7. Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.
Ytting H; Larsen FS
Scand J Gastroenterol; 2015 Aug; 50(8):1025-31. PubMed ID: 25862144
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
Fallatah HI; Akbar HO
Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and therapy of autoimmune hepatitis.
Granito A; Muratori P; Ferri S; Pappas G; Quarneti C; Lenzi M; Bianchi FB; Muratori L
Mini Rev Med Chem; 2009 Jun; 9(7):847-60. PubMed ID: 19519509
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies for autoimmune hepatitis.
Manns MP; Strassburg CP
Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
[TBL] [Abstract][Full Text] [Related]
12. A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.
Zachou K; Gatselis NK; Arvaniti P; Gabeta S; Rigopoulou EI; Koukoulis GK; Dalekos GN
Aliment Pharmacol Ther; 2016 May; 43(10):1035-47. PubMed ID: 26991238
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Autoimmune Hepatitis].
Kim JK
Korean J Gastroenterol; 2023 Feb; 81(2):72-85. PubMed ID: 36824035
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune hepatitis: Current and future therapeutic options.
Doycheva I; Watt KD; Gulamhusein AF
Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis and long-term disease course in children in Turkey, a single-center experience.
Karakoyun M; Ecevit CO; Kilicoglu E; Aydogdu S; Yagci RV; Ozgenc F
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):927-30. PubMed ID: 27254777
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.
Wolf DC; Bojito L; Facciuto M; Lebovics E
Dig Dis Sci; 2009 Nov; 54(11):2519-22. PubMed ID: 19082888
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune hepatitis in children: what is different from adult AIH?
Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
[TBL] [Abstract][Full Text] [Related]
19. Current and novel immunosuppressive therapy for autoimmune hepatitis.
Heneghan MA; McFarlane IG
Hepatology; 2002 Jan; 35(1):7-13. PubMed ID: 11786954
[TBL] [Abstract][Full Text] [Related]
20. Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): Is it justified (and in whom and when)?
Harrison L; Gleeson D
Liver Int; 2019 Apr; 39(4):610-620. PubMed ID: 30667576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
